Skip to main content

NSRX

Nasus Pharma Ltd

Company with tickers: NSRX

CIK
2029039
CUSIP
M7071P109
Shares Outstanding
11,710,808
13F Activity (30d)
8 filings 7 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 9
Total Value: $4,826,884
Total Shares: 2,174,274

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 9 13F filers · Δ vs Dec 31, 2025
Top Holder
41.3%
Sep 2025 → Mar 2026 · range 41.3% – 100.0%
−58.7 pts
Top 5
95.9%
Sep 2025 → Mar 2026 · range 95.9% – 100.0%
−4.1 pts
Top 10
100.0%
Sep 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
2,811
Sep 2025 → Mar 2026 · range 2,811 – 10,000
Highly concentrated−7,189

Quarterly Activity

vs Dec 31, 2025
New
8
Increased
1
Decreased
0
Sold Out
0
Unchanged
0
Holder count: +8
Institutional value: +139486.0%
Shares held: +575104.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
No qualifying movers this quarter.

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
No fully closed positions this quarter.
Showing 9 of 9
Export CSV
Holder Value (USD) % of 13F Shares Open